Validation of a locked nucleic acid based wild-type blocking PCR for the detection of EGFR exon 18/19 mutations

Liesbet Vliegen, Peter Vandenberghe(KU Leuven)

Diagnostic Pathology

May 28, 2015

10.1186/s13000-015-0293-1

Cited by 7

Related Papers

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

|Cancer Cell|2005|3k

Autopsy-Controlled Prospective Evaluation of Serial Screening for Circulating Galactomannan by a Sandwich Enzyme-Linked Immunosorbent Assay for Hematological Patients at Risk for Invasive Aspergillosis

|Journal of Clinical Microbiology|1999|376

The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11)

|Haematologica|2011|61